Why should I cite TRI?
Citing TRI’s support for your research helps ensure the future of clinical and translational research at UAMS. The NIH requires investigators to cite TRI if they used any TRI resources or services to support their research, or received funding through TRI. Additionally, TRI-supported researchers who publish must adhere to the NIH Public Access Policy. This policy has new requirements effective July 1, 2025.
The NIH Public Access Policy applies to any Author Accepted Manuscript accepted for publication in a journal, on or after July 1, 2025, that is the result of funding by NIH in whole or in part through:
- A grant or cooperative agreement, including training grants,
- A contract,
- An Other Transaction,
- NIH intramural research, or
- The official work of an NIH employee.
The NIH Public Access Policy applies regardless of whether the NIH-funded principal investigator or project director is an author and regardless of whether non-IH funds contributed to developing or writing the Author Accepted Manuscript. Authors are responsible for ensuring that this process is completed and that your TRI cited manuscripts are compliant. You can also contact TRI for assistance and questions.
Helpful Links for NIH Public Access Policy
New NIH Public Access Pages to Support the 2024 NIH Public Access Policy
2024 NIH Public Access Policy Notice Number: NOT-OD-25-047
Supplemental Guidance to the 2024 NIH Public Access Policy: Publication Costs. Notice NOT-OD-25-048
When should I cite TRI?
Publications, presentations, or other outcomes resulting from research supported in whole or part by a Translational Research Institute (TRI) resource or service, and any faculty partially or fully supported by TRI are required to:
- Acknowledge the TRI by citing the appropriate grant(s).
- Ensure publications are submitted to PubMed Central and assigned a PMCID. (Instructions and assistance for authors can be found here).
Suggested Citation Language
“Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number <insert appropriate grant number(s) here>. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH.”
Note: for research posters, presentations etc. resulting from your funded research, please also use the below language to acknowledge grant support.
Example language: “Research presented here was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number <insert appropriate grant number(s) here>. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
What constitutes TRI support?
Examples of TRI support include, but are not limited to, the following:
Investigators with pilot, voucher, or mini-grant funding, should cite TRI when the work was done while funded by TRI, or when downstream products directly benefited from pilot funding. Examples of these program include, but are not limited to:
- The UL1 Pilot Award Program,
- Clinical and Translational Science Pilot Program Awards (CTSP2),
- STARs
- Inter-Institutional Pilot Awardees through the Consortium of Rural States (CORES)
- Community Based Participatory Research Scholars Awardees (CBPR)
- Winthrop P. Rockefeller Cancer Institute Rural Research Award Program
Investigators with K or T funding should cite TRI when the work was done while funded by TRI, or when downstream products directly benefitted from K or T research activities. Examples of these programs include:
- Funding through the Mentored Research Career Development Award (KL2 or K12)
- Funding through the Health Sciences Innovation and Entrepreneurship (HSIE) Training Program for Postdoctoral Fellows (TL1 or T32)
Implementation Science Scholars, and MS-CTS Scholars
Services and resources provided through the CTIU such as:
- Biostatistics, qualitative method or study design services received through the BERD
- Informatics resources received through CIRC
- Consulting services
- Research Collaboration support
- Proposal development services
- Navigator Support, or assistance from TRI personnel or CTIU services
Salary support (partial or full) that provides direct benefit to a publication or research product
Note: Downstream publications and research products resulting from non-TRI funded grants but for which the awarded proposal directly benefited from a resource or service should cite TRI.
Which award numbers should I use?
When citing TRI related awards, you should cite all award numbers under which you have received TRI’s support. Support is determined by the date of award.
- Multi-year awards should cite award numbers that correspond with both the initial notice of award date and any subsequent funding years. For example, an awardee who received year one of funding in 2023 and year two in 2024 would need to cite both UL1 TR003107 and UM1 TR004909. If you have any questions about what constitutes support, when your support started, or which grants you should cite, please contact Christi Madden at CMadden2@uams.edu
- For training grants, if you participated in consultations or used TRI support in the development of your application, please cite the main funding award (a “U” number) and the appropriate training award number in your acknowledgement.
Use the tables below to identify which award number(s) you should cite.
Support received between 2024-2029:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 7/1/2024 | 6/30/2029 | K12 TR004924 |
| NCATS | 7/1/2024 | 6/30/2029 | T32 TR004918 |
Support received between 2024-2031:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 7/1/2024 | 6/30/2031 | UM1 TR004909 |
Support received between 2019-2024:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 7/1/2019 | 6/30/2024 | UL1 TR003107 |
| NCATS | 7/1/2019 | 6/30/2024 | KL2 TR003108 |
| NCATS | 7/1/2019 | 6/30/2024 | TL1 TR003109 |
Support received between 2009-2019:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 9/26/2017 | 6/30/2019 | U54 TR001629 |
| NCATS | 4/1/2012 | 3/31/2016 | KL2 TR000063 |
| NCATS | 4/1/2012 | 3/31/2016 | UL1 TR000039 |
| NCRR | 7/14/2009 | 3/31/2012 | UL1 RR029884 |
| NCRR | 7/14/2009 | 3/31/2012 | KL2 RR029883 |